medigraphic.com
ISSN 1561-2945 (Print)

2020, Number 3

<< Back Next >>

Revista Cubana de Cirugía 2020; 59 (3)

Image-guided percutaneous tumor ablation

Vázquez LF, Jordán GJ, González EC

Language: Spanish
References: 31
Page: 1-24
PDF size: 634.27 Kb.


ABSTRACT

The incidence of oncological diseases increases every day. Image-guided percutaneous tumor ablative therapies are treatment alternatives for patients not eligible based on surgical resection criteria. The objective of the study is support the need for the use of percutaneous tumor ablative therapies in Cuba, by reviewing its current state in the world. A descriptive bibliographic review was carried out using the databases Google Scholar, MEDLINE (Pubmed) and SciELO, from which 31 articles were selected, useful to update the information. Percutaneous tumor ablation was performed in view of completely eradicating all viable malignant cells within the tumor. Chemical, thermal and other non-thermal ablations are the most used. This treatment has proven effective and safe. Due to its high cost, its introduction in the country has not been possible.


REFERENCES

  1. Instituto Nacional del Cáncer de los Institutos Nacionales de la Salud de EE.UU. Bethesda MD. 2018 [acceso 15/11/2019]. Disponible en: https://www.cancer.gov/espanol/cancer/naturaleza/estadistica/.

  2. Anuario estadístico de salud 2018. La Habana. 2018 [acceso 15/11/2019]. Disponible en: http://www.sld.cu/sitios/dne/.

  3. Ashikbayeva Z, Tosi D, Balmassov D, Schena E, Saccomandi P, Inglezakis V, et al. Application of Nanoparticles and Nanomaterials in Thermal Ablation Therapy of Cancer. Nanomaterials (Basel). 2019;9(9). DOI: https://doi.org/10.3390/nano9091195.

  4. Singla N, Gahan J. New technologies in tumor ablation. Curr Opin Urol. 2016;26(3):248-53. DOI: https://doi.org/10.1097/MOU.0000000000000284.

  5. Inchingolo R, Posa A, Mariappan M, Spiliopoulos S. Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions. World J Gastroenterol. 2019;25(32):4614-28. DOI: https://doi.org/10.10.3748/wjg.v25.i32.4614.

  6. Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR. Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria-A 10-Year Update. Radiology. 2014;273(1):241-60. DOI: https://doi.org/10.1148/radiol.14132958.

  7. Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee FT Jr., Brace CL. Percutaneous Tumor Ablation Tools: Microwave, Radiofrequency, or Cryoablation-What Should You Use and Why? Radiographics. 2014;34(5):1344-62. DOI: https://doi.org/10.1148/rg.345140054.

  8. Geschwind JF, Dake MD. Abrams' Angiography: interventional radiology. Third Edition. Two Commerce Square 2001 Market Street. Philadelphia: PA; 2014.

  9. Ahmed M, Brace CL, Lee FT, Goldberg SN. Principles of and advances in percutaneous ablation. Radiology. 2011;258(2):351-69.

  10. Weis S, Franke A, Berg T, Mössner J, Fleig WE, Schoppmeyer K, et al. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma. Cochrane Database Syst Rev. 2015;(1). DOI: https://doi.org/10.1002/14651858.CD006745.pub3.

  11. Iniguez-Ariza NM, Lee RA, Singh-Ospina NM. Ethanol ablation for the treatment of cystic and predominantly cystic thyroid nodules. Mayo Clin Proc. 2018 [acceso 12/02/2020];93:1009-17. Disponible en: https://www.clinicalkey.es/refInSitubib1.

  12. Papini E, Pacella CM, Misichi I, Guglielmi R, Bizzarri G, Dossing H, et al. The advent of ultrasound-guided ablation techniques in nodular thyroid disease: Towards a patient-tailored approach. Best Practice & Research Clinical Endocrinology & Metabolism 28. 2014;601-18. Disponible en: http://dx.doi.org/10.1016/j.beem.2014.02.004

  13. Hahn SY. Ethanol Ablation of the Thyroid Nodules: 2018 Consensus Statement by the Korean Society of Thyroid Radiology. Korean J Radiol. 2019;20(4): 609-20. DOI: http://dx.doi.org/10.3348/kjr.2018.0696.

  14. Som PM, Curtin HD. Imaging-Based Intervention: Biopsy and Treatment. Head and Neck Imaging. Mosby: Versión electrónica. 2011 [acceso 12/02/2020). Disponible en: https://www.elsevier.com/books/head-and-neck-imaging-2-volume-set/som/978-0-323-05355-6.

  15. Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, Raoul JL, et al. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018 [acceso 12/02/2020);69:182-236. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/29628281.

  16. Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018 [acceso 12/02/2020);391:1301-14. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/29307467.

  17. Lee DH, Lee JM. Recent Advances in the Image-Guided Tumor Ablation of Liver Malignancies: Radiofrequency Ablation with Multiple Electrodes, Real-Time Multimodality Fusion Imaging, and New Energy Sources. Korean J Radiol. 2018 [acceso 12/02/2020);19:545-559. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/29962861.

  18. Krokidis ME, Kitrou P, Spiliopoulos S, Karnabatidis D, Katsanos K. Image-guided minimally invasive treatment for small renal cell carcinoma. Insights Imaging. 2018 [acceso 12/02/2020);9:385-90. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/29626285.

  19. Crocetti L, Bargellini I, Cioni R. Loco-regional treatment of HCC: current status. Clin Radiol. 2017 [acceso 22/02/2020];72:626-635. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/28258743.

  20. Campbell S, Uzzo RG, Allaf ME, Bass EB, Cadeddu JA, Chang A, Clark PE, Davis BJ, Derweesh IH, Giambarresi L, Gervai DA, Hu SL, Lane BR, Leibovich BC, Pierorazio PM. Renal mass and localized renal cancer: AUA guideline. J Urol. 2017;198:520-9.

  21. Rivero JR, De la Cerda J, Wang H, Liss MA, Farrell AM, Rodriquez R, et al. Partial nephrectomy versus thermal ablation for clinical stage T1 Renal masses: systematic review and meta-analysis of more than 3900 patients. J Vasc Interv Radiol Jan. 2018;29(1):18-29. DOI: https://doi.org/10.1016/j.jvir.2017.08.013.

  22. Kim C. Understanding the nuances of microwave ablation for more accurate post-treatment assessment. Future Oncol. 2018;14(17):1755-64. DOI: https://doi.org/10.2217/fon-2017-0736.

  23. Vogl TJ, Nour-Eldin NA, Albrecht MH, Kaltenbach B, Hohenforst-Schmidt W.Thermal Ablation of Lung Tumors: Focus on Microwave Ablation. Rofo. 2017;189(9):828-43. DOI: https://doi.org/10.1055/s-0043-109010.

  24. Facciorusso A, Serviddio G, Muscatiello N. Local ablative treatments for hepatocellular carcinoma: An updated review. World J Gastrointest Pharmacol Ther. 2016 [acceso 22/02/2020];7:477-489. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095567/.

  25. Pacella CM. Liver Tumors Laser Ablation. Image-guided laser ablation. Springer Nature Switzerland AG. 2020. DOI: https://doi.org/10.1007/978-3-030-21748-8.

  26. Luo W, Zhang Y, He G, Yu M, Zheng M, Liu L, et al. Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas: a systematic review and meta-analysis. World J Surg Oncol. 2017 [acceso 22/02/2020];15:126. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504820/.

  27. Jenne JW, Preusser T, Günther M. High-intensity focused ultrasound: principles, therapy guidance, simulations and applications. Z Med Phys. 2012;22(4):311-22.

  28. Hernández C, Lledó E, Subirá D, Bueno G.Tratamiento conservador del cáncer renal mediante HIFU. Técnica, indicaciones y resultados. Actas Urológicas Españolas 2009 [acceso 22/02/2020];33(5):522-525. Disponible en: https://www.sciencedirect.com/science/article/pii/S0210480609741853

  29. Wu F, Chen WZ, Bai J. Tumor vessel destruction resulting from high intensity focused ultrasound in patients with solid malignancies. Ultrasound Med Biol. 2002 [acceso 22/02/2020];28:535-42. Disponible en: https://www.sciencedirect.com/science/article/pii/S0301562901005154

  30. Lencioni R, Cioni D, Della Pina C, Crocetti L. Hepatocellular carcinoma: new options for image-guided ablation. J Hepatobiliary Pancreat Sci. 2010 [acceso 22/02/2020];17:399-403. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1007/s00534-009-0233-0

  31. Lyu T, Wang X, Su Z, Shangguan J, Sun C. Irreversible electroporation in primary and metastatic hepatic malignancies. A review. Medicine (Baltimore). 2017;96(17):e6386. DOI: https://doi.org/10.1097/MD.0000000000006386.




2020     |     www.medigraphic.com